Approval · Notice of Compliance 2022 · 1999
ACID REDUCER: Notice of Compliance 2022
Issued December 17, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2022
- Date
- December 17, 1999
- Company
- Stanley Pharmaceuticals Ltd.North Vancouver, BC, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Therapeutic class
- Histamine h2 receptor antagonist
- Canadian reference product
- ZANTAC 75 (Glaxo Wellcome Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACID REDUCER | 02241422 | Cancelled Post Market |
Medicinal ingredients
- RANITIDINE HCL 75 MG per TAB